INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?

  This clip examines why shifting study timelines expose weaknesses in rigid RTSM systems and highlights how flexible technology helps trials stay on track when plans inevitably change.

• Empowering Transformation Through Technology

  By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.

• Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It

  Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.

• Patient-Reported Outcome In Oncology Clinical Trials

  As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  1/16/2026

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Deciphering The FDA's Diversity Plan Updated Guidance

  7/16/2024

  Updated FDA guidance from June outlines the format and content of Diversity Action Plans, the products and studies requiring a plan, and the submission process. Learn about the changes and what to expect.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  8/22/2025

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Virtual eConsent For Decentralized Trials

  12/23/2025

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• Facilitate Widespread Outpatient Immunotherapy Treatments With DHTs

  6/6/2025

  An expert panel explores how the industry leverages digital innovation to manage immunotherapy risks and critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.